Teleflex Incorporated (NYSE:TFX) to Post Q2 2026 Earnings of $4.16 Per Share, Zacks Research Forecasts

Teleflex Incorporated (NYSE:TFX) – Equities researchers at Zacks Research raised their Q2 2026 earnings per share (EPS) estimates for Teleflex in a report released on Wednesday, September 25th. Zacks Research analyst R. Department now forecasts that the medical technology company will post earnings of $4.16 per share for the quarter, up from their prior forecast of $4.15. The consensus estimate for Teleflex’s current full-year earnings is $13.97 per share.

Several other research analysts also recently commented on TFX. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $205.00 to $245.00 in a research report on Monday, July 1st. Truist Financial boosted their price objective on shares of Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a research report on Monday, August 5th. Stephens boosted their price objective on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada boosted their price objective on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Stock Up 0.8 %

NYSE TFX opened at $246.83 on Monday. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. Teleflex has a 1-year low of $177.63 and a 1-year high of $257.85. The company has a 50 day moving average of $237.48 and a 200-day moving average of $221.18. The company has a market cap of $11.63 billion, a price-to-earnings ratio of 39.62, a PEG ratio of 2.23 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. During the same period in the previous year, the business earned $3.41 earnings per share. The firm’s quarterly revenue was up .9% on a year-over-year basis.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.55%. Teleflex’s payout ratio is presently 21.83%.

Insiders Place Their Bets

In related news, Director Stuart A. Randle sold 2,674 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.43% of the company’s stock.

Institutional Trading of Teleflex

Institutional investors have recently modified their holdings of the business. Riverview Trust Co bought a new stake in Teleflex during the first quarter valued at $31,000. Pineridge Advisors LLC bought a new stake in Teleflex during the fourth quarter valued at $35,000. Canada Pension Plan Investment Board bought a new stake in Teleflex during the second quarter valued at $42,000. Versant Capital Management Inc boosted its position in Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock valued at $44,000 after acquiring an additional 207 shares during the last quarter. Finally, Blue Trust Inc. raised its holdings in shares of Teleflex by 78.2% during the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after purchasing an additional 93 shares during the period. Institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.